Small Is Green: Reducing Environmental Impact At All Stages Of The Medicine Journey

Are you interested in applying innovative, green technologies to enhance the bioavailability of your drug candidates?

According to a 2019 study, the pharmaceutical industry is estimated to emit 48.55 tonnes of CO2e (carbon dioxide equivalent) per million dollars. This significant contribution to global greenhouse gas emissions – at a time when sustainability is an increasingly important issue for the public and policymakers – is intensifying pressure on the industry to adopt greener processes.

The increasing awareness of the need to be environmentally friendly is driving many larger pharmaceutical companies to invest in internal measures that are designed to improve air quality, water management, or reduce greenhouse gas emissions. With the latest advanced tools, businesses can make nearly every step of the pharmaceutical journey more sustainable – from R&D to manufacturing, and all the way to patient use.

In this article, explore how utilizing technologies like AI and digital twinning can inform decision-making at the R&D stage, how to optimize the delivery of the final drug product to patients with greener logistics, and learn more about selecting a partner who shares the same environmental priorities.